At ACCESS Venture, we work to combat cervical cancer as a public health problem in sub-Saharan Africa where rates of this disease are highest. We believe that resourceful engineering solutions and community engagement come hand in hand in improving accessibility to cervical cancer screening technologies, ultimately contributing to the reduction of cervical cancer incidence and mortality rates.Leveraging UBC's engineering expertise, we are developing a low-cost, user-friendly self-collection Human papillomavirus (HPV) test for women in sub-Saharan Africa. Our multifocal approach involves stakeholder collaboration, community workshops, and rigorous research to ensure that our solution addresses the sociocultural factors, resource limitations, and technological barriers prevalent in the region.In addition to our mission of developing engineering solutions to combat cervical cancer, ACCESS Venture is committed to advancing education on cervical cancer within the communities we serve. We recognize that knowledge is a powerful tool in the fight against this disease, and we aim to empower individuals with information that can help them make informed decisions about their health.